Published in Proteomics Weekly, June 10th, 2002
The Verfaillie laboratory has shown that multipotent adult progenitor cells (MAPCs), a marrow-derived stem cell type with an impressive developmental repertoire, can be prepared from humans or rodents and can be used to reconstitute cells of all embryonic lineages when injected into a blastocyst. Technically more demanding but also more useful if the hope is to develop therapeutic engraftment techniques using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2002-06-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.